Editor's Choice Too much chemotherapy BMJ 2016; 355 doi: https://doi.org/10.1136/bmj.i6027 (Published 10 November 2016) Cite this as: BMJ 2016;355:i6027 Article Related content Metrics Responses Peer review Related articles Letter Something must be done—but chemotherapy isn’t the only option Published: 05 December 2016; BMJ 355 doi:10.1136/bmj.i6455 See more Vaccine hesitancy: an interview with Stanley Plotkin, rubella vaccine developer BMJ December 23, 2019, 367 l6926; DOI: https://doi.org/10.1136/bmj.l6926 Antibiotics: two fifths of US outpatient prescriptions may be inappropriate, study finds BMJ December 12, 2019, 367 l6961; DOI: https://doi.org/10.1136/bmj.l6961 Cochrane launches new research field to tackle overdiagnosis and medical excess BMJ December 07, 2019, 367 l6817; DOI: https://doi.org/10.1136/bmj.l6817 Declining US life expectancy is driven by more than just opioids, study finds BMJ November 29, 2019, 367 l6753; DOI: https://doi.org/10.1136/bmj.l6753 Canadian pharmacist receives award for standing up to campaigners over unproven cancer treatment BMJ November 12, 2019, 367 l6488; DOI: https://doi.org/10.1136/bmj.l6488 Cited by... Something must be done--but chemotherapy isnt the only optionFulltext PDF
